Commenced in January 2007
Frequency: Monthly
Edition: International
Paper Count: 32759
21st Century Biotechnological Research and Development Advancements for Industrial Development in India

Authors: Monisha Isaac

Abstract:

Biotechnology is a discipline which explains the use of living organisms and systems to construct a product, or we can define it as an application or technology developed to use biological systems and organisms processes for a specific use. Particularly, it includes cells and its components use for new technologies and inventions. The tools developed can be further used in diverse fields such as agriculture, industry, research and hospitals etc. The 21st century has seen a drastic development and advancement in biotechnology in India. Significant increase in Government of India’s outlays for biotechnology over the past decade has been observed. A sectoral break up of biotechnology-based companies in India shows that most of the companies are agriculture-based companies having interests ranging from tissue culture to biopesticides. Major attention has been given by the companies in health related activities and in environmental biotechnology. The biopharmaceutical, which comprises of vaccines, diagnostic, and recombinant products is the most reliable and largest segment of the Indian Biotech industry. India has developed its vaccine markets and supplies them to various countries. Then there are the bio-services, which mainly comprise of contract researches and manufacturing services. India has made noticeable developments in the field of bio industries including manufacturing of enzymes, biofuels and biopolymers. Biotechnology is also playing a crucial and significant role in the field of agriculture. Traditional methods have been replaced by new technologies that mainly focus on GM crops, marker assisted technologies and the use of biotechnological tools to improve the quality of fertilizers and soil. It may only be a small contributor but has shown to have huge potential for growth. Bioinformatics is a computational method which helps to store, manage, arrange and design tools to interpret the extensive data gathered through experimental trials, making it important in the design of drugs.

Keywords: Biotechnology, advancement, agriculture, bio-services, bio-industries, bio-pharmaceuticals.

Digital Object Identifier (DOI): doi.org/10.5281/zenodo.1128963

Procedia APA BibTeX Chicago EndNote Harvard JSON MLA RIS XML ISO 690 PDF Downloads 2016

References:


[1] ABLE- Biospectrum Industry survey, June 2013, TechSci Research.
[2] Abhishek Kumar and Lav Srivastava (2012). Biotechnology industry in India: Opportunities or challenges. African Journal of Business Management Vol.6 (44), pp. 10834-10839.
[3] Annual Report 2015-16, Department of Biotechnology Ministry of Science & Technology Government of India
[4] Bagla, P. (2012). Negative reports on GM crops shake Government’s food agenda. Sci. News Anal., 337, 789.
[5] Cammack R. et al. (2009). The Oxford Dictionary of Biochemistry and Molecular Biology, Oxford University Press
[6] Damodaran, A. (2004) Agricultural biotechnology sector in India: Issues impacting innovations, Asian Biotechnology and Development Review, 6(2): 41-51.
[7] FICCI Report, Biotechnology landscape in India, Department of Biotechnology, Government of India.
[8] Ghosh K (2008). “Indian Efforts for Developing Biotechnology”, Asian Biotechnology and Development Review, vol. 11, nº 1, 2008, p. 36. 9. Ibid. p. 43.
[9] IBEF (India Brand Equity Foundation) (2008). Biotech: Market and opportunities. In: A Report of Biotech: Market and Opportunities prepared by Ernst and Young for India Brand Equity Foundation
[10] ISAAA (International Service for the Acquisition of Agribiotech Applications) (2008). Global Status of Commercialized Biotech/GM crops, The First Thirteen Years, 1996 to 2008. ISAAA-Brief 39: Executive Summary.
[11] Kolady, D. E. and Herring, R., Regulation of genetically engineered crops in India: implications of policy paralysis for social welfare, competition and innovation. Can. J. Agric. Econ., 2014, doi: 10.1111/cjag.12055.
[12] Kurmanath, K.V. (2009) Bt cotton increases yields at lower cost, The Hindu Business Line, 24 February.
[13] Manju, Sharma, Charak, K. S. and Ramanaiah, T. V. (2003) Agricultural biotechnology research in India: Status and policies, Current Science, 84 (3): 297-302.
[14] National Biotechnology Development Strategy (2007) Department Of Biotechnology Ministry Of Science & Technology Government Of India.
[15] OEC (2008). OECD Biotechnology Statistics 2009, p. 3. 5. Draft National Regulatory Bill, 2008, art. 2(k).
[16] Policy and rules Department of Biotechnology website, TechSci Research.
[17] Rangasamya N. and K. Elumalaib (2009). Market Opportunities and Challenges for Agri-Biotech Products in India Agricultural Economics Research Review Vol. 22 (Conference Number) 2009 pp 471-481.
[18] Sachin Chaturvedi (2002). Status and Development of Biotechnology in India: An Analytical Overview, RIS Discussion Papers, Research and Information System for the Non-Aligned and Other Developing Countries, RIS-DP # 28/2002.
[19] Rao S. (2010) “Indian Biotechnology Developments in Public and Private Sectors – Status and Opportunities”, Asian Biotechnology and Development Review, June, p. 3.
[20] Revenues of Indian biotech sector surge to $4 bn in FY11, Business Standard, June 17, 2011.
[21] Biospectrum India; Growth slows; June 2009. Biospectrum, June 2010, Vol8, Issue 6, 20.